Shelly, I still can't believe the approval was based on 34% of 100 Women, this goes to show us how Leronlimab will blow those results away, not to mention the side effects as shown below.

Trodelvy side effects
In the phase I/II study, 85% of the people treated with Trodelvy had a severe (grade three or four) side effect. About 32% of the people in the study had serious side effects. Three people stopped treatment because of side effects.

The most common side effects caused by Trodelvy are:

low white blood cell counts
anemia
nausea
diarrhea
fatigue
vomiting
hair loss
constipation
rash
decreased appetite
abdominal pain
The severe side effects that Trodelvy may cause are:

Severe neutropenia: Neutropenia means you have abnormally low levels of neutrophils, a type of white blood cell. People with neutropenia have a much higher risk of getting serious infections. Your doctor will monitor your neutrophil counts while you are being treated with Trodelvy. If you develop neutropenia, you may be treated with a granulocyte-colony stimulating factor medicine such as Neupogen (chemical name: filgrastim), Neulasta (chemical name: pegfilgrastim), or Zarxio (chemical name: filgrastim-sndz).
Severe diarrhea: Severe diarrhea can cause dehydration, low blood pressure, and severe kidney problems. Tell your doctor about any diarrhea you have so it can be treated right away.